Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v7-FR
Language French French
Date Updated 2017-09-18 2017-03-24
Drug Identification Number 02212366 02212366
Brand name ZANTAC ZANTAC
Common or Proper name Ranitidine injection Ranitidine injection
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients RANITIDINE RANITIDINE
Strength(s) 25MG 25MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 2mL x 10's 2mL x 10's
ATC code A02BA A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date
Actual start date 2016-04-25 2016-03-08
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Company comments This product has been discontinued. The 40 mL presentation of ZANTAC® Injeciton 25mg/mL is available.
Health Canada comments